PIMOBENDAN- pimobendan powder

البلد: الولايات المتحدة

اللغة: الإنجليزية

المصدر: NLM (National Library of Medicine)

العنصر النشط:

PIMOBENDAN (UNII: 34AP3BBP9T) (PIMOBENDAN - UNII:34AP3BBP9T)

متاح من:

Attix Pharmaceuticals

طريقة التعاطي:

NOT APPLICABLE

الوضع إذن:

Bulk Ingredient For Animal Drug Compounding

خصائص المنتج

PIMOBENDAN- PIMOBENDAN POWDER
ATTIX PHARMACEUTICALS
REFERENCE LABEL SET ID: CEA1BA8C-448A-45D1-A603-3F39EF6B0450
----------
PIMOBENDAN
PIMOBENDAN
PIMOBENDAN
pimobendan powder
PRODUCT INFORMATION
PRODUCT T YPE
BULK INGREDIENT
ITE M CODE (SOURCE )
NDC:758 39 -0 54
ROUTE OF ADMINISTRATION
NOT APPLICABLE
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
PIMO BENDAN (UNII: 34AP3BBP9 T) (PIMOBENDAN - UNII:34AP3BBP9 T)
PIMOBENDAN
1 g in 1 g
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:758 39 -0 54-25
25 g in 1 CONTAINER
10 /27/20 16
2
NDC:758 39 -0 54-50
50 g in 1 CONTAINER
0 3/14/20 17
Attix Pharmaceuticals
3
NDC:758 39 -0 54-0 0
250 g in 1 BOTTLE
11/14/20 16
4
NDC:758 39 -0 54-0 5
5 g in 1 CONTAINER
11/14/20 16
5
NDC:758 39 -0 54-10
10 0 0 g in 1 BOTTLE
0 5/29 /20 17
6
NDC:758 39 -0 54-11
10 0 g in 1 CONTAINER
11/14/20 16
7
NDC:758 39 -0 54-30
30 0 g in 1 CONTAINER
0 1/16 /20 19
8
NDC:758 39 -0 54-6 0
50 0 0 g in 1 CONTAINER
0 7/0 3/20 19
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH
CITA TIO N
MARKE TING START
DATE
MARKE TING END
DATE
BULK INGREDIENT FOR ANIMAL DRUG
COMPOUNDING
0 4/11/20 13
LABELER -
Attix Pharmaceuticals (248276599)
Revised: 7/2019